Call Us Today! 82.70.8781.6800|info@gsihub.net

Efalizumab

///Efalizumab

Efalizumab

  • Drug / Chemical name: Efalizumab

  • Adverse Effect / Toxicity: Cardiopulmonary failure

  • Species: Human

  • Dose: 1.0 mg/kg/weekly, 11W

  • Dose type: Repeated

  • Route: Subcutaneous

Source link

Adverse Effect / Toxicity: Cardiopulmonary failure

Lotti, T. et al. Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial. Archives of Drug Information 3, 9–18 (2010).
Source link
By | 2016-11-29T03:01:40+00:00 March 20th, 2016|Cardiac Toxicity|Comments Off on Efalizumab

About the Author:

I am an experienced Bio/Cheminformatics Scientist with over 10 years of experience in management and statistical analysis of large datasets and implementations of machine learning approaches. In addition, I am a skilled programmer with affinity with several programming languages including C/C++, Java, and Python.

Related Posts

Toggle Sliding Bar Area
%d bloggers like this: